Trading

Data

Solutions

Insights

Omniome Stock

omniome.comHealthcareFounded: 2013Funding to Date: $153.29MM

Omniome is a biotechnology company developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.

Learn more about Omniome IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for Omniome.

Register Today

Team

Management Team

David Mullarkey

Chief Executive Officer, President & Board Member

Kelly Perez

Senior Vice President of Finance

Arnold Oliphant Ph.D

Chief Technology Officer

Ken Song MD

Executive Chairman

Melissa Tosca

Director, Finance and Accounting

Board Members

David Cruikshank

Kim Kamdar Ph.D

Dan Zabrowski Ph.D

Ken Song MD

Michael Yi

Boris Nikolic MD

Biomatics Capital

David Mullarkey

Other companies like Omniome in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Altos Labs

Sector

Healthcare

Last Round Est. Valuation

$3.67B

Sector

Sector

Last Round Est. Valuation

$1.08B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Headspace

Sector

Healthcare

Last Round Est. Valuation

$298.33MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

OURA

Sector

Healthcare

Allurion Technologies

Sector

Healthcare

News

FINSMES 01/09/2020

Omniome Raises $60M in Series C Financing | FinSMEs

Omniome, Inc., a San Diego, CA-based developer of an innovative DNA sequencing platform, raised an additional $60m and completed the Series C funding

Popular Topics

Popular Topics

Omniome Stock

Register for Details